Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0524 Akp-001
Novel inhibitor of p38 MAP kinase
More description
DCC0523 Akos024836912
Novel Inhibitor of EGF-EGFR Interactions
More description
DCC0522 Ak963/40708899
Novel and potent PAK1 (p21-activated kinase 1) inhibitor, suppressing the proliferation of human gastric cancer cells significantly by downregulation of PAK1-NFκB-CyclinB1 pathway
More description
DCC0521 Ak346zi
Novel antiproliferative agent
More description
DCC0520 Ajh-836
Novel protein kinase C (PKC) activator, preferentially binding to the novel PKC isoforms PKCδ and PKC∈, stimulated a striking preferential redistribution of PKC∈ to the plasma membrane relative to PKCα, inducing major changes in cytoskeletal reorganizatio
More description
DCC0519 Aj-9677
Novel β3-Adrenoceptor agonist, reducing body fat in obese beagles
More description
DCC0518 Aj-108235
Novel inhibitor of long chain fatty acid elongase 6 (ELOVL6)
More description
DCC0517 Aiu2008
Novel FMS-like tyrosine kinase 3 (FLT3) inhibitor, showing improved anti-leukemic efficacy in FLT3-ITD-positive AML cells, specifically inhibiting cell growth and apoptotic death, down-regulating DNA repair genes involved in homologous recombination and n
More description
DCC0516 Aip-iv
Novel quorum sensing (QS) signaling molecule produced by Staphylococcus aureusagr type IV
More description
DCC0515 Ainsliadimer A
Natural selective inhibitor of IKKα/β by covalently binding a conserved cysteine
More description
DCC0514 Ah-487
Microtubule>Tubulin polymerization inhibitor with marked antitumor activities
More description
DCC0513 Agrocybin
Natural inhibitor of Xanthomonas oryzae growth, against rice pathogens
More description
DCC0512 Agp_a4
Novel Keap1-Nrf2 pathway activator by inhibiting the Keap1 protein
More description
DCC0511 Agp_a3
Novel Keap1-Nrf2 pathway activator by inhibiting the Keap1 protein
More description
DCC0510 Agn-2979 Hydrochloride
Inhibitor of tryptophan hydroxylase activation
More description
DCC0509 Agn-201781
alpha Adrenoceptor agonist for the treatment of neuropathic pain
More description
DCC0508 Agn199108
Inhibitor of the basal proton conductance of UCP1; Retinoid, displaying a nonspecific stimulation of NADH oxidation in control mitochondria
More description
DCC0507 Agn194301
Novel potent and specific RARα antagonist
More description
DCC0506 Agn193836
Retinoic Acid Receptor α Subtype Specific Agonist
More description
DCC0505 Agn193312
Novel potent and selective RARα inhibitor
More description
DCC0504 Agi-24512
Novel methionine adenosyltransferase 2A (MATA2 ) inhibitor
More description
DCC0503 Agi-134
Novel inducer of anti-tumor immunity, converting tumors into in situ autologous vaccines
More description
DCC0502 Agathisflavone
Inhibitor of NS2B-NS3 proteases of the Dengue virus serotypes 2 and 3
More description
DCC0501 Agamanone
Anticancer agent with antioxidant and chemopreventive properties
More description
DCC0500 Ag-5507
Novel potent FKBP12 ligand
More description
DCC0499 Ag-5473
Novel potent FKBP12 ligand
More description
DCC0498 Ag2034
Inhibitor of the glycinamide ribonucleotide formyltransferase (GARFT)
More description
DCC0497 Ag1529
Novel capsaicinoid-based soft drug, attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability
More description
DCC0496 Ag1433
Potent inhibitor of tyrosine kinases; Direct and selective inhibitor of photosynthetic PEP carboxylase; Inhibitor of PDGFR-β, Flk-1, and angiogenesis
More description
DCC0494 Ag-012986
pan-Cyclin dependent kinase (CDK) inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X